Author | Trial design | No. of patients | Ovulation rate | Pregnancy rate |
---|---|---|---|---|
Abdel Gadir [19] | LOD | 29 | 71.4% | 52.1% |
HMG | 30 | 70.6% | 38.3% | |
FSH | 28 | 66.7% | Â | |
Balen and Jacobs [28] | Unilateral | 4 | 75% | 0% |
Bilateral LOD | 6 | 33% | 0% | |
Farquhar et al. [39] | LOD | 28 | 54% | 28.5% |
Three cycles HMG/FSH | 19 | 81% per cycle | 21.2% | |
Münstermann and Kleinstein [33] | LOD | 10 | 70% | 50% |
6Â months GnRH analogues followed by three cycles low-dose FSH | 8 | 67% (FSH stimulat.) | 63% | |
Takeuchi et al. [40] | Harmonic scalpel laser | 17 | 94% | 77% |
Nd:YAG laser | 17 | 94% | 60% | |
Bayram et al. [43] | Electrocautery | 83 | 70% | 34% |
Six cycles FSH | 85 | n.a. | 67% | |
Palomba et al. [45] | Metformin | 54 | 54.8% | 18.6% |
LOD | 55 | 53.3% per cycle | 13.4% per cycle |